Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
Clinical trial NCT05115942 · COMPLETED
Trial details
- NCT number
- NCT05115942
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2024-10-22
- Enrollment
- 248
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.